Juan José Araiz Burdio

Juan José Araiz Burdio

Auto-generated profile, based on publicly available information

Juan José Araiz Burdio

Servicio de Medicina Intensiva, Hospital Clínico Universitario Lozano Blesa, Zargoza, Spain

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in World Journal of Gastroenterology
Verified
Journal Article
Open access
Alberto LuéAlberto Lué
Alberto Lué
ESEstela Solanas
Estela Solanas
PBPedro Baptista
Pedro Baptista
SLSara Lorente
Sara Lorente
JAJuan J Araiz
Juan J Araiz
MSM Trinidad Serrano
M Trinidad Serrano
The age of liver donors has been increasing in the past several years because of a donor shortage. In the United States, 33% of donors are age 50 years or older, as are more than 50% in some European countries. The impact of donor age on liver transplantation (LT) has been analyzed in several studies with contradictory conclusions. Nevertheless, recent analyses of the largest databases demonstrate that having an older donor is a risk factor for graft failure. Donor age is included as a risk factor in the more relevant graft survival scores, such as the Donor Risk Index, donor age and Model for End-stage Liver Disease, Survival Outcomes Following Liver Transplantation, and the Balance of Risk. The use of old donors is related to an increased rate of biliary complications and hepatitis C virus-related graft failure. Although liver function does not seem to be significantly affected by age, the incidence of several liver diseases increases with age, and the capacity of the liver to manage or overcome liver diseases or external injuries decreases. In this paper, the importance of age in LT outcomes, the role of donor age as a risk factor, and the influence of aging on liver regeneration are reviewed.

1 September 2012 in American Journal of Transplantation
Verified
Journal Article
Open access
GRG. de la Rosa
G. de la Rosa
BDB. Domínguez-Gil
B. Domínguez-Gil
RMR. Matesanz
R. Matesanz
SRS. Ramón
S. Ramón
JAJ. Alonso-Álvarez
J. Alonso-Álvarez
ASA. Sánchez-Rodríguez
A. Sánchez-Rodríguez
The Spanish Quality Assurance Program applied to the process of donation after brain death entails an internal stage consisting of a continuous clinical chart review of deaths in critical care units (CCUs) performed by transplant coordinators and periodical external audits to selected centers. This paper describes the methodology and provides the most relevant results of this program, with information analyzed from 206,345 CCU deaths. According to the internal audit, 2.3% of hospital deaths and 12.4% of CCU deaths in Spain yield potential donors (clinical criteria consistent with brain death). Out of the potential donors, 54.6% become actual donors, 26% are lost due to medical unsuitability, 13.3% due to refusals to donation, 3.1% due to maintenance problems and 3% due to other reasons. Although the national pool of potential donors after brain death has progressively decreased from 65.2 per million population (pmp) in 2001 to 49 pmp in 2010, the number of actual donors after brain death has remained at about 30 pmp. External audits reveal that the number of actual donors could be 21.6% higher if all potential donors were identified and preventable losses avoided. We encourage other countries to develop similar comprehensive approaches to deceased donation performance.

1 July 2010 in Clinical Transplantation
Verified
Journal Article
Closed access
PDF file
MSMaria Trinidad Serrano
Maria Trinidad Serrano
AGAgustín Garcia‐Gil
Agustín Garcia‐Gil
JAJuan Arenas
Juan Arenas
YBYolanda Ber
Yolanda Ber
LCLuis Cortes
Luis Cortes
JAJuan J. Araiz
Juan J. Araiz

13 April 2011 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
FGFrancisco A. García‐Gil
Francisco A. García‐Gil
MSMaría T. Serrano
María T. Serrano
Lorena Fuentes-BrotoLorena Fuentes-Broto
Lorena Fuentes-Broto
JAJuan Arenas
Juan Arenas
JGJosé J. García
José J. García
MSMiguel A. Simón
Miguel A. Simón

26 April 2016 in Liver Transplantation
Verified
Journal Article
Open access
PDF file
JAJuan J. Araiz
Juan J. Araiz
MSM. Trinidad Serrano
M. Trinidad Serrano
FGFrancisco A. García‐Gil
Francisco A. García‐Gil
ELElena M. Lacruz
Elena M. Lacruz
SLSara Lorente
Sara Lorente
MSMiguel A. Suarez
Miguel A. Suarez
In human immunodeficiency virus (HIV)/hepatitis C virus (HCV) coinfected patients, the accelerated severity of liver disease, associated comorbidities, and mortality on the waiting list could change the possibility and results of liver transplantation (LT). Intention‐to‐treat survival analysis (ITTA) can accurately estimate the applicability and efficacy of LT. The primary objective of this study was to compare the survival of patients with HCV with and without HIV infection. We analyzed a cohort of 199 patients with HCV infection enrolled for LT between 1998 and 2015; 17 were also infected with HIV. The patients with HCV/HIV coinfection had higher mortality on the waiting list than those with HCV monoinfection (35.3% versus 4.6%;P < 0.001). ITTA at 1, 3, and 4 years was 75%, 64%, and 57% for HCV monoinfection and 52%, 47%, and 39% for HCV/HIV coinfection, respectively (Wilcoxon testP < 0.05). The ITTA at 1, 3, 6, and 12 months was 96%, 91%, 87%, and 75% for HCV monoinfection and 76%, 70%, 64%, and 52% for HCV/HIV coinfection, respectively (log‐rankP < 0.05; Wilcoxon testP < 0.01). A Cox regression analysis was carried out including all variables with predictive value in the univariate analysis, showing that only donor age > 70 years (hazard ratio [HR] = 3.12;P < 0.05), United Network for Organ Sharing status 1 (HR = 10.1;P < 0.01), Model for End‐Stage Liver Disease (HR = 1.13;P < 0.001), and HIV coinfection (HR = 2.65;P < 0.05) had independent negative predictive value for survival. In conclusion, our study indicates that HIV coinfection is a factor in mortality prior to transplantation and associated with higher mortality on the waiting list.Liver Transplantation 22 1186–1196 2016 AASLD

1 January 2018 in Revista Española de Enfermedades Digestivas
Verified
Journal Article
Closed access
JBJuan José Araiz Burdio
Juan José Araiz Burdio
MAMaría Trinidad Serrano Aulló
María Trinidad Serrano Aulló
AGAgustín García Gil
Agustín García Gil
ABAna Pascual Bielsa
Ana Pascual Bielsa
Alberto LuéAlberto Lué
Alberto Lué
MPMiguel Ángel Suárez Pinilla
Miguel Ángel Suárez Pinilla
Introduction: several indicators are available to assess liver graft survival, including the American DRI and the European ET-DRI. However, there are significant differences between transplant programs of different countries, and the previously mentioned indicators might be not valid in our setting. Objectives: the aim of the study was to describe a new national liver graft risk indicator based on the results obtained from the Registro Espanol de Trasplante Hepatico (RETH) and to validate the DRI and ET-DRI indicators. Methods: the RETH includes a Cox analysis of factors associated with graft survival; the graft risk index (GRI) indicator was defined based on these results. The variables considered are dependent upon the donation conditions (age, cause of death, blood compatibility and cold ischemia time) and the transplant recipient (age, underlying disease, hepatitis C virus, transplant number, UNOS status and surgical technique). A logistic regression curve was obtained and graft survival curves were calculated by stratification. Precision was assessed using the ROC analysis. Results: a GRI of 1 represents a probability of graft loss of 23.25%; each point increase in the GRI score multiplies this probability by 1.33. The best discrimination of GRI was obtained by stratification.The DRI ROC area was 0.54 (95% CI, 0.50-0.59) and the ET-DRI ROC area was 0.56 (95% CI, 0.51-0.61), compared to 0.70 (95% CI, 0.65-0.73) (p < 0.0001) for the GRI. Conclusions: both the DRI and ET-DRI do not seem to be useful in our setting. Hence a national indicator is more desirable.The GRI requires a national study in order to further streamline and assess this indicator.